Lactosucrose is a man-made, non-digestible sugar that feeds beneficial gut bacteria. Its best-supported effects are raising helpful gut bacteria and improving bowel regularity, with weaker signals for mineral absorption and immune markers. Broader metabolic, weight, and cancer benefits stay unproven. Side effects are mild and dose-related: gas, bloating, and loose stools. (Full Review)

Protocol

Standard Dose

3–6 g/day

Some studies up to ~10 g/day

Dosing Pattern

Split into 2–3 doses

Taken with or near meals

Titration

Start at 1–2 g/day

Increase over 1–2 weeks to allow adaptation

Time to effect

Gut Bacteria Shift

1–2 weeks

Increased bifidobacteria, lower colonic pH

Bowel Regularity

Days to ~2 weeks

Improved stool frequency and consistency

Durability

Use-dependent

Effects plateau, then fade within days to weeks of stopping

Benefits

Medium: Increased beneficial gut bacteria; improved bowel regularity / relief of mild constipation

Low: Enhanced mineral absorption; modulation of immune and inflammatory markers

Speculative: Metabolic and body-weight effects; reduced colorectal cancer risk markers

Contraindications

Galactosemia

Hereditary fructose intolerance

Key Interactions

Osmotic laxatives (lactulose, polyethylene glycol, magnesium hydroxide)

Other prebiotic fibers (inulin, fructooligosaccharides, galactooligosaccharides)

High-dose magnesium supplements

Drugs requiring prolonged intestinal contact time

Risk & Side Effects

Medium: Gastrointestinal discomfort; osmotic diarrhea / loose stools

Speculative: Symptom aggravation in IBS or FODMAP-sensitive individuals; dental and glycemic considerations

Monitoring

Marker	Target	Why
Serum magnesium	0.85–0.95 mmol/L (≈2.1–2.3 mg/dL)	Detects benefit/risk if mineral absorption is a goal
Serum/ionized calcium	9.4–10.0 mg/dL (total)	Monitors calcium status where absorption is a goal
25-hydroxyvitamin D	40–60 ng/mL	Context for calcium/magnesium handling
High-sensitivity C-reactive protein (hs-CRP)	<1.0 mg/L	Optional, if an anti-inflammatory effect is a goal
Fasting glucose	75–90 mg/dL	Reassurance that purity issues are not adding sugar load

Cadence: Reassess after ~8–12 weeks of consistent use, then every 6–12 months if continued.

Qualitative Assessment

Stool frequency & form (Bristol Stool Scale)
Bowel regularity and comfort (frequency, ease, absence of straining)
Bloating, gas, and abdominal comfort
General digestive well-being and appetite
Subjective energy and, anecdotally, mood

Lactosucrose for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment